Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
SPYD vs XLV: how they differ
SPYD and XLV hold 4% of their weight in the same names, and XLV returned more over the year.
State Street(R) SPDR(R) Portfolio S&P 500(R) High Dividend ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, SPYD and XLV hold 4% of their money in the same securities at the same weight.
| Holding | SPYD | XLV |
|---|---|---|
| CVS Health Corp | 1.53% | 2.30% |
| Bristol-Myers Squibb Co | 1.27% | 2.05% |
| Pfizer Inc | 1.12% | 2.40% |
| Viatris Inc | 1.46% | 0.32% |
| Only in SPYD | Only in XLV |
|---|---|
| Iron Mountain Inc 1.62% | Eli Lilly & Co 16.56% |
| Franklin Resources Inc 1.57% | Johnson & Johnson 10.67% |
| Host Hotels & Resorts Inc 1.53% | AbbVie Inc 7.76% |
| Edison International 1.48% | UnitedHealth Group Inc 6.59% |
| Target Corp 1.48% | Merck & Co Inc 5.54% |
| APA Corp 1.48% | Amgen Inc 3.41% |
| Kimco Realty Corp 1.46% | Thermo Fisher Scientific Inc 3.25% |
| Simon Property Group Inc 1.45% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| SPYD State Street(R) SPDR(R) Portfolio S&P 500(R) High Dividend ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | State Street | State Street |
| What it is | SPDR Portfolio S&P 500 High Dividend | Health care |
| Total return, 1 year | +12.9% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −4.6 pts | +2.9 pts |
| Expense ratio | 0.07% | 0.08% |
| Already in the S&P 500 | 100.0% | 100.0% |
| Holdings | 78 | 59 |
SPYD in plain words
SPYD is an index equity fund tracking the SPDR Portfolio S&P 500 High Dividend. Over the year to Sep 11, 2026 it returned +12.9% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.07% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 78 positions, with the top ten at 15.1%. It sat 4.3% below its high of Aug 24, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, SPYD or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, SPYD returned +12.9% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, SPYD or XLV?
- SPYD charges 0.07% a year and XLV charges 0.08%, so SPYD is cheaper. Fees come from each fund's prospectus.
- How much do SPYD and XLV overlap with the S&P 500?
- By their latest filed holdings, 100% of SPYD and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 4% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, SPYD against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/SPYD-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources